The healthcare company will rely on brownfield expansion for driving growth and is also exploring the de-merger or a possible listing of SRL Diagnostics arm, Chief Executive Officer Bhavdeep Singh told CNBC-TV18.
first published: Jun 13, 2016 12:00 am
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

